Developing a coalition roadmap for integration of fungal disease pathways and AMR solutions into health systems in Latin America
GAFFI’s successful advocacy at the global health level needs to be translated into policy and action on a country basis. The size of the fungal diseases problem and their negative impact on health is now obvious in most countries. A new generation of simple diagnostic tools and affordable antifungal are available. Translating all these opportunities into on-the-ground reality requires a health systems approach in each country to generate graduated, sustainable solutions, reducing morbidity and saving lives. The stimulus for this meeting was a paper published in Lancet Infectious Diseases by Cole et al (2017) “Improvement of fungal disease identification and management: combined health systems and public health approaches.”
Timing, location and languages
September 3-5th, 2019; Novotel, Lima, Peru;
Meeting in Spanish, with simultaneous translation
To provide a venue for individual country planning and feedback on options for improvements and donor support for those actions.
LMICs in Latin America: Bolivia, Brazil, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, Guatemala, Honduras, Mexico, Nicaragua, Paraguay, Peru, Venezuela, and HICs – Argentina, Chile, Panama and Uruguay.
We are very grateful to the following companies and institutions for their support of this meeting: Centres for Disease Control, Atlanta, Pan-American Health Organisation, University of Toronto, ISHAM, ECMM, Optimum Imaging Diagnostics, Immy, LDBio, Dynamiker, MiraVista, Tianjin Era-Biology, Omega, Gilead, Scynexis, Pulmocide, Pfizer